CHINA PHARMA HOLDINGS, INC. Shares Granted, Value, Share-based Payment Arrangement, Forfeited
CHINA PHARMA HOLDINGS, INC. (CPHI) had Shares Granted, Value, Share-based Payment Arrangement, Forfeited of $36.27 thousand as of 2022-10-04, per its 10-K filed 2024-04-01.
Discontinued › Shareholders' Equity
us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationForfeited · last filed 2024-04-01
- 2022-10-04: Shares Granted, Value, Share-based Payment Arrangement, Forfeited $36.27K.
- 2021-09-09: Shares Granted, Value, Share-based Payment Arrangement, Forfeited $15.24K.
| Period end | Shares Granted, Value, Share-based Payment Arrangement, Forfeited |
|---|---|
| 2022-10-04 | $36.27K 10-K · filed 2024-04-01 |
| 2021-09-09 | $15.24K 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |